| Literature DB >> 25161906 |
Jemma Cripps1, Ian Beveridge2, Richard Ploeg2, Graeme Coulson3.
Abstract
Large mammalian herbivores are commonly infected with gastrointestinal helminths. In many host species, these helminths cause clinical disease and may trigger conspicuous mortality events. However, they may also have subclinical impacts, reducing fitness as well as causing complex changes to host growth patterns and body condition. Theoretically, juveniles should experience significantly greater costs from parasites, being immunologically naive and undergoing a significant growth phase. The aims of our study were to quantify the subclinical effects of helminths in juvenile eastern grey kangaroos (Macropus giganteus), which commonly harbour large burdens of gastrointestinal nematodes and are susceptible to associated mass mortality during cold, wet conditions. We conducted a field experiment on a population of free-ranging kangaroos, removing nematodes from one group of juveniles using an anthelmintic treatment. We then compared growth parameters (body condition and growth rates) and haematological parameters of this group with an age-matched, parasitised (untreated) control group. Treated juvenile kangaroos had significantly higher levels of plasma protein (albumin) but, contrary to our predictions, showed negligible changes in all the other parameters measured. Our results suggest that juvenile kangaroos are largely unaffected by their gastrointestinal helminth burdens, and may be able to compensate for the costs of parasites.Entities:
Keywords: Costs; Haematology; Helminths; Juveniles; Macropus giganteus; Parasites
Year: 2014 PMID: 25161906 PMCID: PMC4142266 DOI: 10.1016/j.ijppaw.2014.03.005
Source DB: PubMed Journal: Int J Parasitol Parasites Wildl ISSN: 2213-2244 Impact factor: 2.674
Fig. 1Mean faecal egg counts for control and anthelmintic-treated juvenile eastern grey kangaroos in two periods post-capture (12–33 days) and initial treatment (40–90 days) at the Anglesea Golf Club, Victoria, Australia, from March to May 2012. Bars indicate standard errors. It was not always possible to sample each individual in each period; numbers on columns indicate sample size for each time period.
Repeated measures ANOVA of treatment effects on selected ecological growth parameters for control and anthelmintic-treated juvenile eastern grey kangaroos at the Anglesea Golf Club, Victoria, Australia, from May to September 2012. The summaries show the sample size (n), the mean (±SE) increase (first to final capture) and the P-value for each group. The statistical power of this experiment to detect a significant difference between treatment and control groups was calculated for effect sizes of 20% and 80%.
| Parameter | Control | Treated | Power | ||||
|---|---|---|---|---|---|---|---|
| Mean ± SE | Mean ± SE | 20% | 80% | ||||
| Body mass (kg) | 15 | 0.97 ± 0.25 | 12 | 1.33 ± 0.37 | 0.84 | 0.11 | 0.50 |
| Leg (mm) | 15 | 17.30 ± 2.17 | 12 | 19.50 ± 2.58 | 0.93 | 0.26 | 0.99 |
| Body condition (scaled mass index) | 15 | 0.95 ± 1.14 | 12 | 1.22 ± 0.74 | 0.91 | 0.13 | 0.63 |
Summary of the sample size (n), mean (±SE) (at the final capture) and test statistics of selected serum chemistry and haematological parameters for control and anthelmintic-treated juvenile eastern grey kangaroos at the Anglesea Golf Club, Victoria, Australia, from May to September 2012. The statistical power of this experiment to detect a significant difference between treatment and control groups was calculated for effect sizes of 20% and 80%.
| Parameter | Control | Treated | Test-statistic | Power | |||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SE | Mean ± SE | 20% | 80% | ||||||
| Total protein (g/L) | 15 | 61.20 ± 1.39 | 11 | 62.64 ± 1.67 | 24 | 0.51 | 0.99 | 1.0 | |
| Albumin (g/L) | 11 | 27.82 ± 0.57 | 6 | 30.17 ± 0.47 | 15 | 0.01 | 0.99 | 1.0 | |
| Globulin (g/L) | 11 | 31.00 ± 1.14 | 5 | 30.20 ± 1.88 | 14 | 0.71 | 0.86 | 1.0 | |
| Red blood cells (×1012/L) | 15 | 4.48 ± 0.15 | 10 | 4.75 ± 0.14 | 23 | 0.22 | 0.98 | 1.0 | |
| Haemoglobin (g/L) | 15 | 131.53 ± 4.43 | 10 | 139.10 ± 4.03 | – | 0.33 | 0.99 | 1.0 | |
| Haematocrit (L/L) | 15 | 0.37 ± 0.01 | 10 | 0.38 ± 0.01 | – | 0.57 | 0.99 | 1.0 | |
Denotes a significant difference between groups.